|
Invited Speakers:
|
|
Howard Federoff, Chief Medical Officer & Co-Founder, Kenai Therapeutics, FL Irene Rombel, CEO and Co-founder, BioCurie, DE Jim McNally, Chief Scientific Officer, Sword Bio, MA Vladimir Slepushkin, Chief Technology Officer, MedTherapy Biotech, MA Daniel J.Kota, Director, Office of Translational Production and Quality, Houston Methodist, TX Chris Mason, Professor of Cell & Gene Therapy, University College of London, UK Amir Hefni, Chief Executive Officer, Resolution Therapeutics, UK John Zhao, Director Process Development, Kytopen, MA Alessandra De Riva, Head of Process Development and R&D, Advent Bioservices, UK Cassandra Perkins, Director, Value & Access, Channel, Distribution Consulting; Cell & Gene Therapy Consulting, Syneos Health, NC Larry Forman, Founder and CEO, CHO Plus, Inc., CA https://cgtsummit.unitedscientificgroup.org/speakers
|
|